A Patient's Guide to Singulair: Uses, Dosing, Cost, and Adverse Effects - in the UK

Context in conjunction with the essence in brief and expression structure

Montelukast, marketed commonly as Singulair, belongs to a class called leukotriene receptor antagonists. It works by reducing inflammation in the airways and is prescribed to prevent symptoms of asthma and to ease allergic rhinitis linked to seasonal allergies in the United Kingdom.

In UK practice the medicine is supplied in several strengths and formulations to match age and needs. Typical options include 10 mg film-coated tablets for adults, 5 mg and 4 mg chewable tablets, and 4 mg granules for young children. Gaze at the how to take things in stride montelukast section for administration details and side effect and warning notes before the initiation.

• The main active ingredient is montelukast sodium
• Everyday uses: long term control of asthma symptoms and treatment of allergic rhinoconjunctivitis
• Available forms: dosage form: 10 mg tablets, 5 mg chewables, 4 mg chewables, and 4 mg granules for pediatric use

Important facts to know

• Montelukast is used preventively. It helps reduce how often asthma symptoms occur but it does not treat an acute asthma attack. Always have an emergency reliever inhaler available.
• Most regimens call for once daily dosing, taken at about the same time each day, with or without food.
• There have been reports of neuropsychiatric reactions, including changes in mood, sleep disturbances and, rarely, thoughts of self harm. Contact your clinician if you notice such changes.
• In the UK montelukast is classified as a prescription only medicine and must be supplied on a valid prescription.

Prior to initiating montelukast.

Tell the prescriber or pharmacist if any of the following apply to you or the person who will take the medicine:

• Existing liver disease or prior episodes of hepatitis
• A known allergy to montelukast or any ingredient in the product
• Pregnancy, planning a pregnancy or if you are breastfeeding
• Other serious medical conditions or heavy use of other medicines

For children, dosing and suitability should be checked with a paediatrician. If you need advice about storing the product consult the a storage locker can hold tools and supplies. and handling management section title.

How to take responsibility montelukast

Follow the directions on the prescription plus the label. It is preferable to take montelukast at the same time each day to maintain steady effects. When treating children, ask the prescriber or pharmacist if you are uncertain about which formulation or dose to use.

• 10 mg film-coated tablet: swallow whole with water; do not crush or chew.
• 5 mg and 4 mg chewable tablets: chew thoroughly before swallowing.
• 4 mg granules: place directly into the mouth or mix with a small amount of soft food and give immediately after opening the sachet.

If you suspect an consuming an overdose, contact NHS 111, attend your local emergency department or call the local poisons service without delay. For routine checks and follow up see system monitoring and follow up.

In the event you miss a dose

If a dose is omitted, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the the dose was missed and continue your normal dosing schedule. Do not take two doses at the same time in an attempt to cover a the dose was missed.

Conversational interactive engagements in the user journey shape satisfaction. with concomitant medications

Several medicines and some herbal products can alter how montelukast behaves in the body. Always provide a complete list of current medicines, including over the counter products and supplements, to your clinician or pharmacist.

• Rifampicin and rifabutin may decrease montelukast exposure by inducing metabolism
• Certain anticonvulsants such as phenytoin, carbamazepine and phenobarbital may reduce montelukast levels
• Gemfibrozil can raise montelukast exposure
• Drugs metabolised by CYP2C8 such as repaglinide or rosiglitazone could be affected by montelukast
• Perennial herb Hypericum perforatum is an herbal inducer that may lower montelukast concentrations

Additional items may exist beyond this list. When starting new treatment check potential collaborative interactions among teammates fuel progress. with a pharmacist or prescriber.

Ongoing monitoring with follow-up

• Arrange periodic reviews with your GP or asthma clinic to assess symptom control and execute a check for acute side effects.
• Continue to take montelukast even if symptoms improve unless your prescriber advises stopping.
• Remember montelukast does not act quickly in an attack; keep and know how to employ this your reliever inhaler for acute symptoms.

If you notice new or worsening signs contact your prescriber promptly and consider reporting suspected adverse reactions to the MHRA Yellow Card scheme. See adverse outcomes and urgent alerts of potential danger for examples of reactions to report.

Residual effects and urgent safety notices

Seek immediate medical help for:

• Allergic reactions such as rash, hives, swelling of the face, lips or tongue
• Worsening breathing or new severe wheeze
• Signs of liver injury: yellowing of the skin or eyes, dark urine, unexplained bruising
• High fever or other signs of serious infection
• Sudden onset of severe nerve pain or facial swelling
• New or worsening psychiatric symptoms including severe anxiety, agitation, depression or suicidal thoughts

More common, generally mild effects

• Head pressure or dizzy spell
• Trouble sleepings such as insomnia or vivid dreams
• Mild stomach upset
• Minor upper respiratory complaints like cough or nasal congestion

If you develop troubling effects report them to your clinician and consider submitting a Yellow Card report to the MHRA. For follow up advice see monitoring and logging and follow up.

Handling together with the storage of files is essential for data management. practices

• Store medications in a location out of sight and out of children's reach.
• Store at normal room temperature, typically between 15 and 30 degrees C (59 to 86 degrees F).
• Protect packs from excessive moisture and strong light; retain medicines in their original container until use.
• Do not use after the expiry date on the label. Dispose of unwanted medicine at a pharmacy or follow local disposal mentoring and guidance.

If a child swallows any medicine accidentally call NHS 111 or local emergency services immediately. For dosage guidelines return to how to take medicine montelukast.

Associated options and similar therapies

Montelukast is one of several options for managing allergic rhinitis and asthma. The best choice depends on symptom pattern, severity, age and past treatment responses.

• Other leukotriene pathway agents: zafirlukast (less commonly used in the UK) and zileuton in some countries
• Inhaled corticosteroids for maintenance therapy: beclometasone, budesonide, fluticasone
• Combination inhalers (ICS plus long acting bronchodilator): examples include budesonide/formoterol and fluticasone/salmeterol
• Short acting relievers for acute symptoms: salbutamol (albuterol)
• Allergy symptomatic treatments: non sedating antihistamines such as cetirizine or loratadine and intranasal steroid sprays
• Specialist biologic agents for severe asthma managed in secondary care: omalizumab, mepolizumab, benralizumab and dupilumab

Discuss the benefits, accompanying effects and likely costs of other routes in dialog with your prescriber. See tentative price points in the United Kingdom for private cost comparisons.

Price suggestions for the United Kingdom

Private costs vary by supplier, brand and pack size. The figures below are approximate and intended as a rough guide in pounds sterling (GBP).

• Generic montelukast 10 mg, pack of 28: approximately £6 to £15 privately
• Branded Singulair 10 mg, pack of 28: roughly £25 to £45 privately
• Chewable tablets or granules (4 mg or 5 mg): about £4 to £12 depending on pack size
• Private consultation or e prescription fees: typically add about £10 to £30
• NHS prescription charge in England (2026): £9.90 per item for most patients; prescriptions are free to eligible groups and vary in Scotland, Wales and Northern Ireland.

For context, many single ingredient inhaled corticosteroid inhalers may cost around £10 to £30 privately, combination inhalers £40 to £70, and biologic therapies are high cost and normally arranged through NHS specialist services for eligible patients.

The legal framework in the United Kingdom

• Montelukast (Singulair) is a Prescription Only Medicine under the Human Medicines Regulations 2012.
• It must be supplied on a valid UK prescription and dispensed by a pharmacy registered with the General Pharmaceutical Council (GPhC). Distance selling pharmacies must also be GPhC registered.
• Purchasing montelukast from overseas or unregulated online sellers without a prescription is unsafe and unlawful.
• When travelling with prescribed medicines carry them in the original packaging and, where possible, keep a copy of the prescription or a clinician letter. Check import rules for the destination country.
• If montelukast causes drowsiness or dizziness do not drive or operate machinery until you know how it affects you.
• Suspected adverse reactions should be reported via the MHRA Yellow Card scheme; see chronic side effects and urgent heads up notices.

Bibliography and where to get help

• Discuss individual treatment plans and an asthma action plan with your GP, community pharmacist or respiratory specialist.
• For urgent medical advice use NHS 111 or your local emergency department.
• For details on optimized storage layouts improve overall efficiency., dosing and adverse reactions review inventory storage keeps products ready for sale. and handling tasks, how to take medication montelukast and unintended consequences and urgent risk warnings.

This page provides general information and does not replace personalised medical advice from a qualified healthcare professional.